REGISTERED NUMBER: 03234036 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 December 2024

for

EDLESBOROUGH PHARMACEUTICAL SUPPLIES

LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mrs U Patel

M Patel

REGISTERED OFFICE:

Edlesborough Pharmacy

11 Cow Lane Edlesborough

Dunstable

Bedfordshire

LU6 2HT

REGISTERED NUMBER:

03234036 (England and Wales)

ACCOUNTANTS:

K G Solanki & Co.

Hamilton House

315 St Saviours Road

Leicester

Leicestershire

LE5 4HG

FIXED ASSETS

Tangible assets

4

32,615

42,653

CURRENT ASSETS

Stocks

107,135

75,922

Debtors

5

2,270,097

1,987,067

Cash at bank and in hand

444,088

377,713

2,821,320

2,440,702

CREDITORS

Amounts falling due within one year

6

381,165

288,974

NET CURRENT ASSETS

2,440,155

2,151,728

TOTAL ASSETS LESS CURRENT LIABILITIES

2,472,770

2,194,381

PROVISIONS FOR LIABILITIES

8,154

10,805

NET ASSETS

2,464,616

2,183,576

CAPITAL AND RESERVES

Called up share capital

110

110

Retained earnings

2,464,506

2,183,466

SHAREHOLDERS' FUNDS

2,464,616

2,183,576

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 16 September 2025 and were signed on its behalf by:

M Patel - Director

1.	STATUTORY INFORMATION

Edlesborough Pharmaceutical Supplies Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 14 (2023 - 13 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machiner

etc

£

COST

At 1 January 2024

77,477

Additions

833

At 31 December 2024

78,310

DEPRECIATION

At 1 January 2024

34,824

Charge for year

10,871

At 31 December 2024

45,695

NET BOOK VALUE

At 31 December 2024

32,615

At 31 December 2023

42,653

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Trade debtors

177,949

139,449

Amounts owed by group undertakings

2,039,702

1,794,702

Other debtors

52,446

52,916

2,270,097

1,987,067

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Trade creditors

276,466

204,082

Taxation and social security

97,014

76,148

Other creditors

7,685

8,744

381,165

288,974

7.	CONTINGENT LIABILITIES

On 17th November 2022 the company assigned fixed and floating charges on the assets of the company in favour of Lloyds Bank plc, as security for debt provided by the Bank to the parent company , Yashnidhi Limited.

8.	RELATED PARTY DISCLOSURES

During the year , management fees of £120,000 ( 2023 £120,000) were paid to the parent company Yashnidhi Limited.

9.	ULTIMATE CONTROLLING PARTY

On 31st October 2018 the company became a wholly owned subsidiary of Yashnidhi Limited , a company incorporated in England & Wales.